Salt AI, a life sciences AI development workflow platform, raised $10 million in a pre-Series A round at a $29 million valuation, CEO Aber Whitcomb exclusively tells Axios Pro.
Why it matters: The company plans to begin fundraising a formal Series A round in early 2026.
